Overview

A Study of Effects of Fesoterodine in Men at High Risk for Overactive Bladder/Detrusor Overactivity Post Robotic-Assisted Lap. Prostatectomy

Status:
Completed

Trial end date:
2013-04-15

Target enrollment:

Participant gender:

Summary

The investigators will assess the incidence of Overactive Bladder/Detrusor Overactivity (OAB/DO) post-operatively in patients post robotic assisted radical prostatectomy (RARP) and to investigate whether fesoterodine will alter the incidence of OAB/DO in these patients. Additionally, the correlation between OAB symptoms and urodynamic DO will be analyzed.

Phase:

Phase 4

Details

Lead Sponsor:

Abramson Cancer Center of the University of Pennsylvania

Treatments:

Fesoterodine